Chemokine drives tuberculosis
نویسندگان
چکیده
منابع مشابه
Chemokine drives tuberculosis
Organs such as the lung that are continuously exposed to inhaled microbes must be carefully guarded against excessive inflammation. A new study by Taggart and colleagues on page 1659 shows that a protease inhibitor that is produced in the airways helps subdue lung inflammation by shutting down the pro-inflammatory transcription factor NFB, both in the cytoplasm and the nucleus. One way the lung...
متن کاملMMP-1 drives immunopathology in human tuberculosis and transgenic mice.
Mycobacterium tuberculosis can cause lung tissue damage to spread, but the mechanisms driving this immunopathology are poorly understood. The breakdown of lung matrix involves MMPs, which have a unique ability to degrade fibrillar collagens at neutral pH. To determine whether MMPs play a role in the immunopathology of tuberculosis (TB), we profiled MMPs and their inhibitors, the tissue inhibito...
متن کاملAqueous cytokine and chemokine analysis in uveitis associated with tuberculosis
PURPOSE The aim of this study was to study the aqueous cytokine and chemokine composition in patients with uveitis associated with tuberculosis (TAU). METHODS We present a prospective case series of consecutive new patients with active uveitis presenting at a single tertiary center (January 1, 2008-January 1, 2010). Patients with no ocular pathology other than cataracts were enrolled as non-i...
متن کاملIL-33 Drives Monocyte Recruitment to Lung Interstitium through Chemokine Upregulation
Tissue infiltration by circulating monocytes is a critical step in the initiation and augmentation of type 2 inflammatory responses in the lungs. Our studies demonstrate that IL-33-/- mice have a defect in monocyte extravasation from the vasculature to the lung interstitium during induction of type 2 inflammatory responses. This result suggests that monocyte migration to the lungs is IL-33 depe...
متن کاملERK-dependent downregulation of the atypical chemokine receptor D6 drives tumor aggressiveness in Kaposi sarcoma.
D6 is an atypical chemokine receptor acting as a decoy and scavenger for inflammatory CC chemokines expressed in lymphatic endothelial cells. Here, we report that D6 is expressed in Kaposi sarcoma (KS), a tumor ontogenetically related to the lymphatic endothelium. Both in human tumors and in an experimental model, D6 expression levels were inversely correlated with tumor aggressiveness and incr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Experimental Medicine
سال: 2005
ISSN: 1540-9538,0022-1007
DOI: 10.1084/jem20212iti2